Stay updated on Dupilumab for Eosinophilic Gastritis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.

Latest updates to the Dupilumab for Eosinophilic Gastritis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing v3.4.1, indicating a minor site update without changes to study details or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page adds and removes several metadata and UI elements, including 'Show glossary', 'Results First Posted', and 'Last Update Posted', while older labels such as 'Results First Posted (Estimated)' are removed; capitalization adjustments (e.g., 'No FEAR Act Data') accompany the move to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check39 days agoChange DetectedRevision stamp updated to v3.3.4, replacing the previous v3.3.3.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a Locations section detailing the trial sites by state (Colorado, Illinois, Indiana, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, Texas, Utah). Removed the separate Colorado Locations reference and HHS Vulnerability Disclosure.SummaryDifference1%

- Check89 days agoChange DetectedRevision label at the bottom of the page updated from v3.3.1 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Dupilumab for Eosinophilic Gastritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for Eosinophilic Gastritis Clinical Trial page.